Radius Health (RDUS) Financials

$30.00

$0.00 (0.00%)

As on 10-Jul-2025 16:03EDT

Market cap

$848 Mln

Revenue (TTM)

$2,797 Mln

P/E Ratio

--

P/B Ratio

1.6

Div. Yield

2.5 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Aug-24	Aug-23	Aug-22	Dec-21	Aug-21	Dec-20	Aug-20	Dec-19	Aug-19	Dec-18
Operating Revenue	2,796.85	2,738.69	2,882.22	3,485.82	229.97	2,758.55
Cost of Revenue	2,634.37	2,561.59	2,574.51	2,997.75	19.15	2,305.36
Gross Profit	162.48	177.10	307.71	488.07	210.82	453.19
Operating Expenses	232.07	471.08	265.93	263.26	265.14	242.46
Operating Profit (EBIT)	-69.59	-293.98	-3.93	225.91	-54.32	213.73
Other Income	--	--	--	-0.69	2.40	-0.46
Profit before Tax	-104.76	-321.43	-28.08	216.68	-70.18	207.99
Provision for Tax	-2.57	-55.29	-2.75	44.60	--	37.94
Profit after Tax (Net Income)	-103.19	-266.41	-25.79	168.80	-70.18	165.11
Minority Interest	-0.99	-0.19	-0.35	3.20	--	-4.86
Consolidated Profit	--	--	--	168.80	-70.18	165.11

Liabilities ($ Mln)	TTM	Aug-24	Aug-23	Aug-22	Dec-21	Aug-21	Dec-20	Aug-20	Dec-19	Aug-19	Dec-18
Shareholder's Funds	525.61	623.11	908.18	953.98	-252.30	835.76
Minority Interest	-0.99	--	--	4.50	--	4.02
Non-Current Liabilities	634.28	591.46	480.36	486.55	339.06	301.73
Current Liabilities	309.81	316.57	323.93	381.57	94.79	352.85
Total Liabilities	309.81	1,533.77	1,715.95	1,826.60	181.54	1,494.36

Assets ($ Mln)	TTM	Aug-24	Aug-23	Aug-22	Dec-21	Aug-21	Dec-20	Aug-20	Dec-19	Aug-19	Dec-18
Non-Current Assets	898.21	924.64	1,165.61	1,155.21	8.46	951.25
Current Assets	573.99	609.13	550.34	671.39	173.08	543.11
Total Assets	1,782.01	1,533.77	1,715.95	1,826.60	181.54	1,494.36
Total Debt*	--	538.28	365.31	371.87	339.67	209.54
Net Current Assets	264.18	292.56	226.41	289.81	78.29	190.26

Cashflow ($ Mln)	TTM	Aug-24	Aug-23	Aug-22	Dec-21	Aug-21	Dec-20	Aug-20	Dec-19	Aug-19	Dec-18
Cash From Operating Activities	--	-53.41	139.36	237.68	-22.43	190.06
Cash Flow from Investing Activities	--	-78.64	-143.97	-316.15	23.21	-117.65
Cash from Financing Activities	--	131.47	-33.13	94.57	19.32	-62.82
Net Cash Inflow / Outflow	--	--	--	16.10	20.10	9.59

Financials Ratios	TTM	Aug-24	Aug-23	Aug-22	Dec-21	Aug-21	Dec-20	Aug-20	Dec-19	Aug-19	Dec-18
Adjusted EPS ($)	--	--	--	--	-1.48	--
Cash EPS ($)	--	--	--	--	-1.46	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	--	--	-0.47	--
Free Cash Flow per Share ($)	--	--	--	--	-0.47	--

Profitability Ratios	TTM	Aug-24	Aug-23	Aug-22	Dec-21	Aug-21	Dec-20	Aug-20	Dec-19	Aug-19	Dec-18
ROCE (%)	--	-21.88	-1.98	23.89	415.23	35.73
ROE (%)	-18.84	-34.80	-2.77	48.11	37.33	46.37
ROA (%)	-5.66	-16.40	-1.46	16.81	-37.62	19.59
EBIT Margin (%)	-2.47	-10.75	-1.79	4.36	-22.58	5.64
Net Margin (%)	-3.69	-9.73	-0.89	4.84	-30.20	5.99
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Aug-24	Aug-23	Aug-22	Dec-21	Aug-21	Dec-20	Aug-20	Dec-19	Aug-19	Dec-18
Revenue Growth (%)	4.13	-0.05	-0.17	0.26	-0.04	0.61
EBIT Growth (%)	77.80	-472.47	-133.89	-2.49	37.18	523.96
Net Profit Growth (%)	62.28	-932.96	-115.28	2.23	35.74	4,083.40
EPS Growth (%)	--	--	--	--	0.37	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	TTM	Aug-24	Aug-23	Aug-22	Dec-21	Aug-21	Dec-20	Aug-20	Dec-19	Aug-19	Dec-18
Price / Earnings	--	--	--	--	-4.67	--
Price / Book Value	1.61	--	--	--	-1.30	--
Dividend Yield (%)	2.50	--	--	--	--	--
EV/EBITDA	51.98	-2.69	9.38	1.45	-10.95	0.85
Close Price ($)	29.61	15.14	33.20	33.04	51.92	47.31
High Price ($)	29.68	33.92	36.64	59.70	59.34	59.34
Low Price ($)	10.57	12.69	25.96	29.79	27.72	18.78
Market Cap ($ Cr)	847.73	--	--	--	--	--

Solvency Ratios	TTM	Aug-24	Aug-23	Aug-22	Dec-21	Aug-21	Dec-20	Aug-20	Dec-19	Aug-19	Dec-18
Debt to Equity	0.85	0.86	0.40	0.39	-1.35	0.25
Short term debt to equity ratio	--	0.04	0.03	0.03	0.00	0.03
Current Ratio	1.85	1.92	1.70	1.76	1.83	1.54
Quick Ratio	0.97	1.00	0.84	0.93	1.71	0.81
Interest Coverage	-1.94	-10.95	-2.77	17.78	-2.84	29.46

Operating Efficiency Ratios	TTM	Aug-24	Aug-23	Aug-22	Dec-21	Aug-21	Dec-20	Aug-20	Dec-19	Aug-19	Dec-18
Debtors to sales (%)	8.55	9.46	7.30	6.82	10.16	7.76
Asset Turnover	1.53	1.69	1.63	3.47	1.23	3.27
Receivable days	--	31.31	28.39	13.67	34.68	15.52
Inventory Days	--	40.82	42.12	19.89	195.95	21.04
Payable days	--	29.37	30.30	14.34	262.73	15.04
Cash Conversion Cycle	--	42.76	40.22	19.23	-32.11	21.52

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.